A peritoneal dialysis registered nurse (pdrn) reported that the patient is a bedbound patient and was not hospitalized but visited the emergency room (er) on (b)(6) 2024.The patient was experiencing hypotension for some time and was being treated with midodrine medication.The pdrn confirmed that none of the events were related to the pd therapy or the use of fresenius products.She stated that the patient was doing well and continuing with pd treatment.While on the call, the pdrn stated that the patient was hospitalized in february for peritonitis, but she had no further information about the event.Upon follow up, it was reported this patient was hospitalized on (b)(6) 2024 following abdominal pain and cloudy peritoneal effluent fluid.Peritoneal effluent fluid cultures and a white blood cell (wbc) count taken in the hospital on (b)(6) 2024 presented with no growth in the culture and a wbc count of 612/mm3.The patient was diagnosed with peritonitis due to unknown etiology.The patient was prescribed intraperitoneal (ip) vancomycin at 2000 mg and ip ceftazidime at 2000 mg (frequency and duration not reported) to address the infection.It was believed the patient was able to undergo ccpd therapy on a hospital provided cycler for the duration of the admission.The patient had an uneventful hospital course and was discharged to home on (b)(6) 2024.It was confirmed, though the exact cause of this adverse event remains unknown, there was no indication the patient¿s peritonitis, and the associated hospitalization were due to a deficiency or malfunction of any fresenius product(s) or device(s).The patient recovered from this event as he remains asymptomatic and continues ccpd therapy on the same liberty select cycler at home post-discharge.
|